NEVVI Medicare utilization intelligence
+ Build a code basket
Medicare Arizona · CY2024

Who bills the most Injection, pembrolizumab, 1 mg (J9271) to Medicare in Arizona?

Medicare Part B FFS · CY2024 · as published by CMS
17
Billing groups
836,836
Named-group FFS services
$125,483,593
Named-group submitted charges
$150
Avg charge / service
$56
Avg allowed / service
77%
Top-5 concentration
0%
Independent share

17 physician groups billed Injection, pembrolizumab, 1 mg (J9271) to Medicare fee-for-service in Arizona in 2024; the top five named groups hold 77% of that volume, and independent (non-hospital-affiliated) groups deliver 0%.

J9271 — Injection, pembrolizumab, 1 mg · Source: CMS Medicare Physician & Other Practitioners PUF (Part B), CY2024 release. Medicare fee-for-service only.

Snapshot covers the whole Arizona market — the table below shows the top 100 groups (free tier).

Payer-mix context

Medicare fee-for-service covers 49% of Medicare in Arizona; Medicare Advantage penetration 42% → 51% since 2020.

Market structure — concentration, independent share, and the consolidation trend for this market — is part of the market analytics platform — built, not launched yet. Notify me at launch →
#Physician groupCityStSpecialty Providers J9271 svcs Share*Phone
1 MAYO CLINIC ARIZONA PHOENIXAZPHYSICIAN ASSISTANT 1635 249,604 23.1% (800) 603-0558
2 IRONWOOD PHYSICIANS PC MESAAZHEMATOLOGY/ONCOLOGY 114 229,710 21.2% (480) 981-1326
3 TMC MEDICAL NETWORK TUCSONAZNURSE PRACTITIONER 273 84,140 7.8% (520) 324-4230
4 CITY OF HOPE MEDICAL GROUP OF ARIZONA LLC GOODYEARAZNURSE PRACTITIONER 157 41,500 3.8% (623) 207-3000
5 PALO VERDE HEMATOLOGY ONCOLOGY LTD PHOENIXAZPHYSICIAN ASSISTANT 16 35,600 3.3% (623) 478-8091
6 ARIZONA BLOOD AND CANCER SPECIALISTS, PLLC TUCSONAZMEDICAL ONCOLOGY 15 27,200 2.5% (520) 689-7022
7 SOUTHWEST CANCER CARE LLC SIERRA VISTAAZNURSE PRACTITIONER 6 24,600 2.3% (520) 220-5020
8 AMERICAN ONCOLOGY PARTNERS PA FORT WAYNEAZHEMATOLOGY/ONCOLOGY 333 23,701 2.2% (260) 484-8830
9 THE ONCOLOGY INSTITUTE CA, A PROFESSIONAL CORPORATION LAKEWOODAZHEMATOLOGY/ONCOLOGY 110 21,600 2.0% (562) 232-0550
10 HEMATOLOGY-ONCOLOGY ASSOCIATES OF NORTH JERSEY LLC KINGMANAZHEMATOLOGY/ONCOLOGY 3 20,006 1.9% (928) 681-1234
11 ARIZONA ONCOLOGY ASSOCIATES PC TUCSONAZDIAGNOSTIC RADIOLOGY 48 18,800 1.7%
12 PHOENIX CANCER AND BLOOD DISORDER TREATMENT INSTITUTE PLLC BULLHEAD CITYAZINTERNAL MEDICINE 2 17,200 1.6% (928) 219-1357
13 SJHMC PHYSICIAN SERVICES PHOENIXAZNURSE PRACTITIONER 690 13,800 1.3% (602) 406-6017
14 BANNER-UNIVERSITY MEDICAL GROUP TUCSONAZINTERNAL MEDICINE 1068 11,380 1.1% (520) 694-0111
15 HONORHEALTH AMBULATORY SCOTTSDALEAZPHYSICIAN ASSISTANT 601 7,795 0.7%
16 HRMC, LLC LAKE HAVASU CITYAZNURSE PRACTITIONER 32 5,600 0.5% (928) 453-3761
17 SINGING RIVER HEALTH SYSTEM PASCAGOULAAZNURSE PRACTITIONER 282 4,600 0.4% (228) 818-0563

*Share of Arizona's disclosed Medicare-FFS services for J9271, counted once per clinician. Volume is placed in the state it was billed from, so this page ranks the groups actually billing J9271 in Arizona — including groups registered elsewhere ("City" is each group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group.

How to read this. Figures are Medicare fee-for-service only — not all-payer — from the CMS Medicare Physician & Other Practitioners Public Use File (Part B), CY2024 release. CMS suppresses any provider×code row under 11 beneficiaries, so a missing group means "suppressed," never zero. "Charges" are provider-submitted amounts, not payments. Groups are ranked by measured service volume attributed to clinicians in exactly one group — clinicians affiliated with several groups are listed in rosters but never volume-attributed to a single group — a direct read of the public record, not a rating or quality score. Full method: Methods & Sources.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →